Trial Profile
Effects of pramlintide on glucose kinetics and postprandial insulin sensitivity in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Aug 2013
Price :
$35
*
At a glance
- Drugs Pramlintide (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 27 Sep 2013 Results presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.
- 09 Aug 2013 New trial record